Tag: CIRSE 2019
Novel embolization agent “promising” for the endovascular treatment of cerebral aneurysms...
The first preclinical study of a novel embolization agent, GPX, reports its successful performance in a rabbit aneurysm model. High rates of complete angiographic...
1,550-patient study indicates prostate artery embolization effective for a decade
Prostate artery embolization (PAE) may become the standard of care procedure for the management of symptomatic benign prostatic hyperplasia (BPH), proposed Tiago Bilhim (CHULC,...
CIRSE 2019: Medicare data shows women “missing out” on uterus-sparing surgery...
Gerard Goh (Melbourne, Australia) talks to BLearning IR at CIRSE 2019 (Cardiovascular and Interventional Radiological Society of Europe; 7–11 September; Barcelona, Spain) about Australian public Medicare data which...
SINGA-PACLI results do not support routine use of drug-coated balloon in...
The prospective, randomised SINGA-PACLI trial sought to compare the results of drug-coated balloon (DCB) treatment to plain balloon angioplasty (POBA) for the treatment of...
TINTIN trial shows “impressive” results at six months
The six-month results of TINTIN (Treatment with the lumINor DCB and The IVolutioN self-expanding stent) trial have been revealed at the annual meeting of the Cardiovascular and...
CIRSE 2019: Teaching materials to follow curriculum in IO education
CIRSE 2019 Gold Medal awardee, Thierry de Baère (Villejuif, France), tells Interventional News at the society’s annual meeting (7-11 September, Barcelona, Spain) that this...
Preliminary results of first European prospective study find GAE reduces pain...
Geniculate artery embolization (GAE) is responsible for statistically significant improvements in pain scores from baseline out to three months, the preliminary results of the...
IN.PACT AV access trial meets primary safety and effectiveness endpoints
Medtronic has announced the first-ever results from the IN.PACT AV access clinical study comparing the investigational IN.PACT AV drug-coated balloon (DCB) to percutaneous transluminal...
